[HTML][HTML] A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis

T Sawicki, M Ruszkowska, A Danielewicz… - Cancers, 2021 - mdpi.com
Simple Summary According to the available data, colorectal cancer (CRC) is one of the most
common malignant neoplasms. Depending on the location, type of cancer or gender, it is …

Epigenetic aging: more than just a clock when it comes to cancer

M Yu, WD Hazelton, GE Luebeck, WM Grady - Cancer research, 2020 - AACR
The incidence of cancer, adjusted for secular trends, is directly related to age, and advanced
chronologic age is one of the most significant risk factors for cancer. Organismal aging is …

[HTML][HTML] Right and left-sided colon cancers-specificity of molecular mechanisms in tumorigenesis and progression

K Mukund, N Syulyukina, S Ramamoorthy… - BMC cancer, 2020 - Springer
Background Given the differences in embryonic origin, vascular and nervous supplies,
microbiotic burden, and main physiological functions of left and right colons, tumor location …

[HTML][HTML] Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients

TK Nikolouzakis, L Vassilopoulou… - Oncology …, 2018 - spandidos-publications.com
Colorectal cancer (CRC) is among the most common cancers. In fact, it is placed in the third
place among the most diagnosed cancer in men, after lung and prostate cancer, and in the …

[HTML][HTML] Epigenetic IVD tests for personalized precision medicine in cancer

J Beltrán-García, R Osca-Verdegal… - Frontiers in …, 2019 - frontiersin.org
Epigenetic alterations play a key role in the initiation and progression of cancer. Therefore, it
is possible to use epigenetic marks as biomarkers for predictive and precision medicine in …

[HTML][HTML] The protective effect of polyphenols for colorectal cancer

S Ding, S Xu, J Fang, H Jiang - Frontiers in immunology, 2020 - frontiersin.org
Colorectal cancer (CRC) is one of the most prevalent cancers that threaten people in many
countries. It is a multi-factorial chronic disease caused by a combination of genetic and …

Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates

A Mahasneh, F Al-Shaheri, E Jamal - Experimental and molecular …, 2017 - Elsevier
Colorectal cancer (CRC) is the third most prevalent cancer in the world. Globally, it has been
estimated that about 1.4 million new cases of colorectal cancer are diagnosed every year …

[HTML][HTML] Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives

HM Vedeld, A Goel, GE Lind - Seminars in cancer biology, 2018 - Elsevier
Abstract Each year, almost 4.1 million people are diagnosed with gastrointestinal (GI)
cancers. Due to late detection of this disease, the mortality is high, causing approximately 3 …

Early epigenetic markers for precision medicine

RG Dumitrescu - Cancer Epigenetics for Precision Medicine: Methods …, 2018 - Springer
Over the last years, epigenetic changes, including DNA methylation and histone
modifications detected in early tumorigenesis and cancer progression, have been proposed …

[HTML][HTML] DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples

EA Laugsand, SS Brenne, F Skorpen - International Journal of Colorectal …, 2021 - Springer
Purpose Methylated cell-free DNA in liquid biopsies are promising non-invasive biomarkers
for colorectal cancer (CRC). Optimal markers would have high sensitivity and specificity for …